NLRC5 germline variants as potential pharmacogenomic markers for immune checkpoint inhibitors
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMJ Publishing Group
2023-06-01
|
| Reeks: | Journal for ImmunoTherapy of Cancer |
| Online toegang: | https://jitc.bmj.com/content/11/6/e007255.full |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|